Inventor · disambiguated record
Pradeep Sharma
Also filed as: SHARMA PRADEEP · SHARMA PRADEEP K · SHARMA PRADEEP KUMAR
17 granted patents·11 pending applications·46 citations·filing 1998–2023
91Inventor score
Files withARIAD PHARMA INC15TAKEDA PHARMACEUTICALS CO4JOHNSON MATTHEY PLC3BHAGWATWAR PRABHAKAR H1CHEMOURS CO FC LLC1
Top patents by PatentIndex Score
28 records- 0195US9493470B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2013·Granted Nov 15, 2016·16 cites·17 claims
- 0289US10125136B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2016·Granted Nov 13, 2018·3 cites·12 claims
- 0388US10662197B2Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2018·Granted May 26, 2020·4 cites·11 claims
- 0485US7109371B2Prostaglandin synthesisJOHNSON MATTHEY PLC·Filed 2004·Granted Sep 19, 2006·18 cites·48 claims
- 0584US2024083902A1Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 0684US2024043457A1Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4[(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0779US11192896B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·18 claims
- 0878US11192895B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·24 claims
- 0978US11192897B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·23 claims
- 1078US2024082275A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1177US11384086B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Jul 12, 2022·0 cites·19 claims
- 1274US11279705B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2020·Granted Mar 22, 2022·0 cites·3 claims
- 1372US11427605B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2020·Granted Aug 30, 2022·0 cites·8 claims
- 1471US2022249524A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1569US2021401860A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1668US7161042B2Protected diols for prostaglandin synthesisJOHNSON MATTHEY PLC·Filed 2006·Granted Jan 9, 2007·1 cites·8 claims
- 1766US10934317B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2019·Granted Mar 2, 2021·0 cites·13 claims
- 1866US2021186994A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 1956US10385078B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2015·Granted Aug 20, 2019·0 cites·8 claims
- 2055US2018256610A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2018·Application pending·0 cites
- 2153US7141706B2Protected and unprotected triols for prostaglandin synthesisJOHNSON MATTHEY PLC·Filed 2006·Granted Nov 28, 2006·0 cites·11 claims
- 2252US12084431B2Pharmaceutical salts of pyrimidine derivatives and method of treating disordersARIAD PHARMA INC·Filed 2019·Granted Sep 10, 2024·0 cites·30 claims
- 2347US12071582B2Process and methods for reclaiming flammable and non-flammable hydrofluoro-olefin containing refrigerantsCHEMOURS CO FC LLC·Filed 2020·Granted Aug 27, 2024·0 cites·35 claims
- 2446US2006286130A1Sterile gelling agentsBHAGWATWAR PRABHAKAR H·Filed 2005·Application pending·0 cites
- 2545US2007004796A1Processes for the preparation of protected-(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4B,8)-epicatechin or -catechin dimers and their digallatesROMANCZYK LEO JR·Filed 2005·Application pending·0 cites
- 2643US2010048920A1Preparation of (+)-Catechin, (-)-Epicatechin, (-)-Catechin, and (+)-Epicatechin and Their 5,7,3',4'-Tetra-O-Benzyl AnaloguesMARS INC·Filed 2006·Application pending·0 cites
- 2740US2004049049A1Stereoselective synthesis of 1,2-disubstituted cycloalkylsJOHNSON MATTHEY PHARMACEUTICAL·Filed 2003·Application pending·0 cites
- 2838US6051711ASynthesis of swainsonine saltsGLYCODESIGN INC·Filed 1998·Granted Apr 18, 2000·4 cites·53 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →